Exhibit 107
Calculation of Filing Fee Tables
424(b)(5)
(Form Type)
Syndax Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial Effective Date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||
Feeds to be Paid | Equity | Common stock, $0.0001 par value per share | Rule 457(r) | 7,840,909(2) | $22.00 | $172,499,998 | $110.20 per $1,000,000 | $19,010 | ||||||||||||||||
Fees Previously Paid | — | — | — | — | — | — | — | — | ||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||
Carry Forward Securities | — | — | — | — | — | — | — | — | — | |||||||||||||||
Total Offering Amounts | $19,010(1) | |||||||||||||||||||||||
Total Fees Previously Paid | — | |||||||||||||||||||||||
Total Fee Offsets | — | |||||||||||||||||||||||
Net Fee Due | $19,010 |
(1) | Calculated in accordance with Rule 457(r) under the Securities Act of 1933, as amended, and relates to our Registration Statement on Form S-3ASR (File No. 333-254661). |
(2) | Includes 1,022,727 shares of common stock issuable upon exercise of the underwriters’ option to purchase additional shares of common stock. |